CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 150 enrolled
Drug / intervention
Glaucoma Implantprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04052165
NCT04052165N/ACompleted

IOP Reduction and Complications of Polymethyl Methacrylate Glaucoma Drainage Device on Glaucoma Patient

Indonesia University·interventional·Posted Aug 9, 2019·Updated Aug 25, 2021

In Brief

A clinical study evaluating Glaucoma Implant for Glaucoma Eye. Completed, enrolled 150 participants across 1 site.

Detailed Summary

Glaucoma is a group of diseases that damage the eye's optic nerve, result in progressive visual field defect and blindness. The aim of glaucoma management is to reduce IOP, and glaucoma implant surgery is the alternative treatment that can be chosen. The effectiveness of the implant on the end stage glaucoma patients was evaluated by the reduction of intra ocular pressure (IOP) and well formed blebs that were evaluated clinically and by using anterior scanning optical coherence tomography (AS-OCT). The safety of the implant was determined by the regression of the clinical symptoms and there were no severe complications such as implant extrusion. Two patients developed improvement of the visual acuity. This was an unpredictable positive result.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsGlaucoma Eye
CountriesIndonesia

Timeline

N/ACompletedFinished
20162017201820192020202120222023202420252026
First PostedAug 9, 2019
Enrollment StartJul 1, 2015
Primary CompletionAug 1, 2019
Study CompletionAug 8, 2020
TodayJul 2, 2026
Enrollment to primary: 4.1 yearsPosted 6.9 years ago

Interventions

Glaucoma Implantprocedure